Crossmark

Soft-donor dipicolinamide derivatives for selective actinide(<scp>iii</scp>)/lanthanide(<scp>iii</scp>) separation: the role of S- <i>vs.</i> O-donor sites

Crossref DOI link: https://doi.org/10.1039/C8CC07683A

Published Online: 2019

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Lehman-Andino, Ingrid

Su, Jing https://orcid.org/0000-0002-6895-2150
Papathanasiou, Konstantinos E.

Eaton, Teresa M.

Jian, Jiwen

Dan, David https://orcid.org/0000-0001-6855-2627
Albrecht-Schmitt, Thomas E. https://orcid.org/0000-0002-2989-3311
Dares, Christopher J. https://orcid.org/0000-0003-2255-6619
Batista, Enrique R. https://orcid.org/0000-0002-3074-4022
Yang, Ping https://orcid.org/0000-0003-4726-2860
Gibson, John K. https://orcid.org/0000-0003-2107-5418
Kavallieratos, Konstantinos https://orcid.org/0000-0002-2670-9398
Funding

Funding for this research was provided by:

U.S. Nuclear Regulatory Commission (NRC-HQ-84-14-G-0040, NRC-HQ-84-15-G-0038)

Office of Science (DE-SC0016568)
License Information

Accepted Manuscript valid from 2020-01-30
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

: Crystal Structure Data

IDENTIFIERS

: Jing Su (ORCID)

: Jing Su (ResearcherID)

: David Dan (ORCID)

: Thomas E. Albrecht-Schmitt (ORCID)

: Christopher J. Dares (ORCID)

: Enrique R. Batista (ORCID)

: Ping Yang (ORCID)

: John K. Gibson (ORCID)

: Konstantinos Kavallieratos (ORCID)

PEER REVIEW METHOD

: Authors can choose between single-blind and double-blind peer review

PUBLICATION HISTORY

: Received 24 September 2018; Accepted 30 January 2019; Accepted Manuscript published 30 January 2019; Advance Article published 8 February 2019; Version of Record published 21 February 2019

Document is current

Any future updates will be listed below